A 62-year-old man was admitted for his first renal transplantation in August 2001. Immunosuppressive therapy consisted of anti-thymocyte globulin, ciclosporin A, mycophenolate mofetil and steroids. On Day 1 post-transplantation, haemorrhagic shock occurred, leading to massive blood transfusion, surgical re-intervention and delayed graft function (DGF). A large haematoma developed at the transplant site.

One month later, DGF was still present and the patient developed severe sepsis. A renal biopsy was performed and showed isolated acute tubular necrosis, explaining the DGF, and unexpectedly a few glomeruli and tubes contained yeast forms that were characteristic of *Candida albicans* (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Blood cultures were also positive for *C. albicans* as were transplant site haematoma cultures.

![Silver stain (×400) showing intraglomerular yeast (*Candida albicans*) (yellow arrows) in two different glomeruli associated with inflammatory reaction in the urinary chamber.](sfp051fig1){#F1}

![PAS stain (A ×200; B × 320) showing intratubular *Candida albicans* (black arrows) associated with inflammatory reaction in and around the tube.](sfp051fig2){#F2}

*C. albicans* septicaemia was treated with 15-day intravenous amphotericin B together with 1-month treatment with fluconazole and evacuation of the haematoma.

One month later (2 months after kidney transplantation), renal function had recovered, and the patient was discharged from the hospital with a plasma creatinine level of 240 μmol/l.

To the best of our knowledge, there is only one published report of intraglomerular yeast \[[@R1]\] in an HIV-infected patient. Our own report of severe candidaemia after kidney transplantation associated with the intra-glomerular presence of *C. albicans* would appear to be the only reported case to date.[](#F1){ref-type="fig"}[](#F2){ref-type="fig"}
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